Phase I safety and bioimaging trial of KB004 (ifabotuzumab) in patients with glioblastoma
Year: 2020
Type: article
Study design: Clinical Trial
Source: Journal of Nuclear Medicine
Authors: Hui Gan, Lawrence Cher, Po Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Alex McDonald, Uwe Ackermann, Nicole Coombs, Kristen Remen, Nancy Guo, Sze Ting Lee, Sylvia Gong, Jodie Palmer, Kunthi Pathmaraj, Graeme O’Keefe, Fiona E. Scott, Bryan W. Day, Andy Boyd, Paul Thomas, Omar Ahmed, Dave Chappell, Cameron Durrant, Andrew M. Scott
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3128908947